[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] SHRESTHA AD,VEDSTED P,KALLESTRUP P,et al.Prevalence and incidence of oral cancer in low-and middle-income countries:A scoping review[J].Eur J Cancer Care (Engl),2020,29(2):e13207.
[3] LIU TPJ,FISHER BM,CHUA B,et al.Survival outcomes following modern multidisciplinary management of oral squamous cell carcinoma in Australia[J].Oral Surg Oral Med Oral Pathol Oral Radiol,2021,131(1):92-98.
[4]MULLER S,TILAKARATNE WM.Update from the 5th edition of the World Health Organization classification of head and neck tumors:Tumours of the oral cavity and mobile tongue[J].Head Neck Pathol,2022,16(1):54-62.
[5] KAUR J,SRIVASTAVA R,BORSE V.Recent advances in point-of-care diagnostics for oral cancer[J].Biosens Bioelectron,2021,178:112995.
[6] ALMANGUSH A,MAKITIE AA,TRIANTAFYLLOU A,et al.Staging and grading of oral squamous cell carcinoma:An update[J].Oral Oncol,2020,107:104799.
[7]WISHART,DAVID S.Is cancer a genetic disease or a metabolic disease[J].EBioMedicine,2015,2(6):478-479.
[8]陈炳宇,黄四洲.一碳代谢路径通路在癌症发生中作用研究进展[J].中国细胞生物学学报,2019,41(6):1201-1206.
CHEN BY,HUANG SZ.Research progress on the role of one carbon metabolic pathway in cancer genesis [J].Chin J Cell Biol,2019,41(6):1201-1206.
[9] FIELD MS,KAMYNINA E,AGUNLOYE OC,et al.Nuclear enrichment of folate cofactors and methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) protect de novo thymidylate biosynthesis during folate deficiency[J].Biol Chem,2014,289(43):29642-29650.
[10] LAN X,FIELD MS,STOVER PJ.Cell cycle regulation of folate-mediated one-carbon metabolism[J].Wiley Interdiscip Rev Syst Biol Med,2018,10(6):e1426.
[11] AGARWAL S,BEHRING M,HALE K,et al.MTHFD1L,a folate cycle enzyme,is involved in progression of colorectal cancer[J].Transl Oncol,2019,12(11):1461-1467.
[12] EICH ML,PENA M,CHANDRASHEKAR DS,et al.Expression and role of methylenetetrahydrofolate dehydrogenase 1 like (MTHFD1L) in bladder cancer[J].Transl Oncol,2019,12(11):1416-1424.
[13] YANG YS,YUAN Y,HU WP,et al.The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma[J].Scand J Gastroenterol,2018,53(5):533-540.
[14] WANG L,YANG Y,WANG XM,et al.MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway[J].J Recept Signal Transduct Res,2020,40(6):584-590.
[15] MESIA R,IGLESIAS L,LAMBEA J,et al.SEOM clinical guidelines for the treatment of head and neck cancer (2020)[J].Clin Transl Oncol,2021,23(5):913-921.
[16] KIM D,LI R.Contemporary treatment of locally advanced oral cancer[J].Curr Treat Options Oncol,2019,20(4):32-40.
[17] NAGAO T,WARNAKULASURIYA S.Screening for oral cancer:Future prospects,research and policy development for Asia[J].Oral Oncol,2020,105:104632.
[18] DEKHNE AS,HOU Z,GANGJEE A,et al.Therapeutic targeting of mitochondrial one-carbon metabolism in cancer[J].Mol Cancer Ther,2020,19(11):2245-2255.
[19] YANG C,ZHANG J,LIAO M,et al.Folate-mediated one-carbon metabolism:a targeting strategy in cancer therapy[J].Drug Discov Today,2021,26(3):817-825.
[20] REN RJ,WANG LL,FANG R,et al.The MTHFD1L gene rs11754661 marker is associated with susceptibility to Alzheimer's disease in the Chinese Han population[J].J Neurol Sci,2011,308(1-2):32-34.
[21] SHIN M,VAUGHN A,MOMB J,et al.Deletion of neural tube defect-associated gene Mthfd1l causes reduced cranial mesenchyme density[J].Birth Defects Res,2019,111(19):1520-1534.
[22] MOODY M,LE O,RICKERT M,et al.Folic acid supplementation increases survival and modulates high risk HPV-induced phenotypes in oral squamous cell carcinoma cells and correlates with p53 mRNA transcriptional down-regulation[J].Cancer Cell Int,2012,12(1):1-12.
[23] MCCABE J,CHANG S,HAJIBANDEH J,et al.Folate supplementation induces differential dose-dependent modulation of proliferative phenotypes among cancerous and noncancerous oral cell lines in vitro[J].J Diet Suppl,2010,7(4):325-340.
[24] LEE D,XU IM,CHIU DK,et al.Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma[J].J Clin Invest,2017,127(5):1856-1872.
[25] LI H,FU XY,FAN Y,et al.MTHFD1L-mediated redox homeostasis promotes tumor progression in tongue squamous cell carcinoma[J].Front Oncol,2019,9:1278-1278.
[26] TIAN X,WANG Y,LI S,et al.ZHX2 inhibits proliferation and promotes apoptosis of human lung cancer cells through targeting p38MAPK pathway[J].Cancer Biomark,2020,27(1):75-84.
[27] GAN L,CHEN Y,LIU H,et al.Long non-coding RNA ZEB1-antisense 1 affects cell migration and invasion of cervical cancer by regulating epithelial-mesenchymal transition via the p38MAPK signaling pathway[J].Gynecol Obstet Invest,2019,84(2):136-144.
[28] SAHU V,NIGAM L,AGNIHOTRI V,et al.Diagnostic significance of p38 isoforms (p38α,p38β,p38γ,p38δ) in head and neck squamous cell carcinoma:comparative serum level evaluation and design of novel peptide inhibitor targeting the same[J].Cancer Res Treat,2019,51(1):313-325.
[29]ESPINOSA-COTTON M,RODMAN III SN,ROSS KA,et al.Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma[J].J Immunother Cancer,2019,7(1):79-94.